UNICA IRIS Institutional Research Information System

COLUMBANO, AMEDEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 243.916
NA - Nord America 9.878
AS - Asia 2.078
SA - Sud America 294
OC - Oceania 21
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 256.210
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 240.231
US - Stati Uniti d'America 9.782
NL - Olanda 1.071
CN - Cina 1.028
UA - Ucraina 880
SG - Singapore 710
SE - Svezia 615
DE - Germania 421
BR - Brasile 263
FI - Finlandia 257
GB - Regno Unito 224
FR - Francia 82
CA - Canada 73
TR - Turchia 68
IN - India 45
VN - Vietnam 43
HK - Hong Kong 26
BE - Belgio 24
KR - Corea 24
RU - Federazione Russa 24
IR - Iran 22
AU - Australia 20
JP - Giappone 18
ID - Indonesia 16
AT - Austria 14
BD - Bangladesh 13
MX - Messico 13
AR - Argentina 12
ES - Italia 11
PL - Polonia 11
SA - Arabia Saudita 10
IE - Irlanda 9
IQ - Iraq 8
ZA - Sudafrica 8
IL - Israele 7
PK - Pakistan 7
LT - Lituania 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 4
EC - Ecuador 4
EG - Egitto 4
EU - Europa 4
RO - Romania 4
AZ - Azerbaigian 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
MT - Malta 3
PE - Perù 3
UZ - Uzbekistan 3
AL - Albania 2
BY - Bielorussia 2
CO - Colombia 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
LK - Sri Lanka 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
PY - Paraguay 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BT - Bhutan 1
CL - Cile 1
DO - Repubblica Dominicana 1
GE - Georgia 1
IM - Isola di Man 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SC - Seychelles 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 256.210
Salva come PNG Salva come JPEG
Città #
Cagliari 236.146
Uta 3.609
Fairfield 1.293
Amsterdam 1.053
Woodbridge 854
Ashburn 804
Chandler 792
Houston 607
Wilmington 529
Boardman 520
Ann Arbor 489
Seattle 485
Nyköping 471
Jacksonville 463
Cambridge 440
Singapore 388
Dearborn 245
Beijing 225
Nanjing 152
Santa Clara 148
Helsinki 103
Boston 99
San Diego 76
Shanghai 76
Los Angeles 67
Guangzhou 60
Toronto 59
Kocaeli 58
Shenyang 57
Nanchang 56
New York 53
Redwood City 53
Hebei 51
Falls Church 49
San Mateo 48
Changsha 47
Mountain View 45
The Dalles 42
Munich 40
Dong Ket 36
Milan 36
Jiaxing 34
London 29
Jinan 26
Norwalk 25
Auburn Hills 24
Hefei 24
Brussels 23
Hong Kong 23
Leawood 22
Augusta 21
Orange 21
São Paulo 21
Tianjin 21
Seoul 20
Verona 20
Rome 19
Millbury 18
Minneapolis 17
Nuremberg 16
Atlanta 15
Council Bluffs 15
Ardabil 14
Turku 14
Zhengzhou 14
Chicago 12
Columbus 12
Frankfurt am Main 12
Ningbo 12
Phoenix 12
Washington 12
Monmouth Junction 11
Walnut 11
Brooklyn 10
Pune 10
Warsaw 10
Wuhan 10
Dublin 9
Düsseldorf 9
Kilburn 9
Pisa 9
Sassari 9
Tappahannock 9
Kunming 8
San Francisco 8
Curitiba 7
Detroit 7
Portsmouth 7
Rio de Janeiro 7
Taizhou 7
Tel Aviv 7
Torino 7
Borås 6
Indiana 6
Madrid 6
Milwaukee 6
Tokyo 6
Bangalore 5
Boulder 5
Chiswick 5
Totale 251.718
Salva come PNG Salva come JPEG
Nome #
null 13.191
Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype 5.948
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 4.908
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice 4.154
YAP activation is an early event and a potential therapeutic target in liver cancer development 3.943
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats 3.874
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats 3.772
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells 3.678
Alpha-lipoic acid promotes the growth of rat hepatic preneoplastic lesions in the choline deficient model 3.631
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis 3.619
Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells 3.597
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.578
Emerging role of the pentose phosphate pathway in hepatocellular carcinoma 3.531
Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor 3.500
Induction of hepatocyte proliferation by retinoic acid 3.253
Clustered protocadherins methylation alterations in cancer 3.235
Sex difference in the proliferative response of mouse hepatocytes to treatment with the CAR ligand TCPOBOP 3.181
The peroxisome proliferator BR931 kills FaO cells by p53-dependent apotosis 3.138
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). 3.102
MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. 3.095
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 3.082
Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3) 3.060
Potential utility of xenobiotic mitogens in the context of liver regeneration in the elderly and living-related transplantation 3.058
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules 2.997
The thyromimetic KB2115 (Eprotirome) induces rat hepatocyte proliferation 2.898
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 2.846
Regulatory effects of senescence marker protein 30 on the proliferation of hepatocytes 2.738
Reply to: "YAP in tumorigenesis: Friend or foe?" 2.721
A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis 2.658
Progenitor-derived hepatocellular carcinoma model in the rat 2.656
T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair 2.586
Timed regulation of P-element-induced wimpy testis-interacting RNA expression during rat liver regeneration 2.578
High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist 2.575
Estimation of a significance threshold for epigenome-wide association studies 2.524
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression 2.477
Thyroid hormone induces cyclin D1 nuclear translocation and DNA synthesis in adult rat cardiomyocytes 2.456
The thyroid hormone receptor-beta agonist GC-1 induces cell proliferation in rat liver and pancreas 2.433
Induction of pancreatic acinar cell proliferation by thyroid hormone 2.416
null 2.399
Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis 2.356
Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene 2.335
Ciprofibrate and triiodothyronine do not suppress in vivo induction of placental glutathione S-transferase expression in rat hepatocytes 2.332
Reply to: Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: comparison in mice and humans 2.311
Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease 2.273
Gadd 45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia 2.261
Gadd45β is an inducible coactivator of transcription that facilitates rapid liver growth in mice 2.157
Proteomic characterization of early changes induced by triiodothyronine in rat liver 2.120
Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation 2.069
Cell proliferation induced by 3,3',5 triiodo L thyronine is associated with a reduction in the number of preneoplastic hepatic lesions 2.062
Triiodothyronine induces hepatocyte proliferation by protein kinase A-dependent-b-catenin activation in rodents. 2.051
DEXAMETHASONE INHIBITS INDUCTION OF LIVER-TUMOR NECROSIS FACTOR-ALPHA MESSENGER-RNA AND LIVER GROWTH INDUCED BY LEAD NITRATE AND ETHYLENE DIBROMIDE 2.030
Thyroid hormone receptor-β agonist induces β-catenin-dependent hepatocyte proliferation in mice: Implications in hepatic regeneration 1.904
AGING DOES NOT REDUCE THE HEPATOCYTE PROLIFERATIVE RESPONSE OF MICE TO THE PRIMARY MITOGEN TCPOBOP 1.881
Different effects of regenerative and direct mitogenic stimuli on the growth of initiated cells in the resistant hepatocyte model 1.817
METODO PER RILEVARE E/O PER LA PROGNOSI DI NEOPLASIE DEL COLON-RETTO 1.795
A large set of miRNAs is dysregulated from the earliest steps of human hepatocellular carcinoma development 1.783
Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis 1.771
miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling 1.736
Different effects of the liver mitogens triiodo-thyronine and ciprofibrate on the development of rat hepatocellular carcinoma 1.735
Dexametasone inhibits induction of liver Tumor Necrosis Factor-a mRNA and liver growth induced by lead nitrate and ethylene dibromide 1.723
Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas 1.705
The dual roles of NRF2 in cancer 1.688
Thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin-Driven Hepatocellular Cancer 1.675
Loss of cyclin D1 does not inhibit the proliferative response of mouse liver to mitogenic stimuli 1.650
Increased expression of c.fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP 1.642
Peroxisome proliferator-activated receptor-alpha(-/-) mice show enhanced hepatocyte proliferation in response to the hepatomitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene, a ligand of constitutive androstane receptor 1.607
Differential effects of choline administration on liver microsomes of female and male rats 1.599
Constitutive androstane receptor (Car)-driven regeneration protects liver from failure following tissue loss 1.591
Differences in the steady-state levels of c-fos, c-jun and c-myc messanger RNA during mitogen-induced liver growth and compensatory regeneration 1.588
Animal models: A useful tool to unveil metabolic changes in hepatocellular carcinoma 1.574
Studies on the kinetics of expression of cell cycle dependent proto-oncogenes during mitogen-induced liver cell proliferation 1.530
MicroRNA: New Tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? 1.523
Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of trascription factors NF-kB and AP-1 or expression of tumor necrosis factor-alfa 1.458
Met as a therapeutic target in HCC: Facts and hopes 1.423
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 1.388
An electron microscopic study of apoptosis induced by cycloheximide in rat liver 1.376
A common set of immediate-early response genes in liver regeneration and hyperplasia 1.356
Mitogenesis by ligands of nuclear receptors: an attractive model for the study of the molecular mechanisms implicated in liver growth 1.143
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 1.143
Early ultrastructural changes during thioacetamide-induced apoptosis in rat liver 1.133
Genome-wide single nucleotide polymorphysm analysis of lung cancer risk detects the KLF6 gen 1.068
The TRbeta-selective agonist, GC-1, stimulates mitochondrial oxidative processes to a lesser extent than triiodothyronine 1.020
null 951
Hexose monophosphate shunt and cholesterogenesis in lead-induced kidney hyperplasia 914
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 884
Tg68, a novel thyroid hormone receptor‐β agonist for the treatment of NAFLD 877
HMP-shunt and cholesterol metabolism in experimental models involving normal and preneoplastic liver growth. 851
Stimulation of DNA synthesis after a single administration of cadmium nitrate. 847
Roles of growth factors and of tumor necrosis factor-alpha on liver cell proliferation induced in rats by lead nitrate 835
T3 and the thyroid hormone beta-receptor agonist GC-1 differentially affect metabolic capacity and oxidative damage in rat tissues 832
Cell proliferation in rat kidney induced by 1,2-dibromoethane 828
Induction of 2 different modes of cell-death, apoptosis and necrosis, in rat-liver after a single dose of thioacetamide 826
Induction of cellular DNA synthesis in the pancreas and kidneys of rats by peroxisome proliferators, 9-cis retinoic acid, and 3,3',5-triiodo-L-thyronine 818
Occurence of cell death (Apoptosis) during the involution of liver hyperplasia 816
Further evidence that mitogen-induced cell proliferation does not support the formation of enzyme-altered islands in rat liver by carcinogens 806
Liver hyperplasia is not necessarily associated with increased expression of c-fos and c-myc mRNA 802
Liver hyperplasia and regression after lead nitrate administration 798
Cell deletion by apoptosis during regression of renal hyperplasia. 789
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 783
Effects of cell proliferation and cell death (apoptosis and necrosis) on the early stages of rat hepatocarcinogenesis 770
Totale 224.495
Salva come PNG Salva come JPEG
Categoria #
all - tutte 314.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 314.425
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157.514 1.806 2.393 2.386 14.835 11.191 6.752 5.396 3.982 1.408 2.878 2.957 1.530
2021/202213.864 1.847 1.210 687 919 1.129 1.048 748 561 1.468 1.236 1.423 1.588
2022/202319.224 1.491 2.529 2.506 1.704 1.674 1.833 994 1.502 1.175 1.324 1.568 924
2023/202419.982 1.380 925 1.896 1.415 1.808 2.537 2.702 1.442 910 1.379 1.788 1.800
2024/202530.988 7.855 8.128 3.496 3.015 1.668 2.020 2.223 180 336 1.351 299 417
2025/2026417 417 0 0 0 0 0 0 0 0 0 0 0
Totale 256.571